Dr. UWERA Roselyne Pediater SRL

Dr. UWERA Roselyne Pediater reported total assets of 304,521 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Dec 2025).

Company number (CBE) 0743.380.680
3350 Linter
operating since 06 Feb 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. UWERA Roselyne Pediater shows with a free account.

See the score
Profile
SRL since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result23,694 €
Equity5,473 €
Cash89,619 €
EBITDA86,344 €
Total assets304,521 €

Change 2022 → 2025: Equity -80 % Total assets -20 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. UWERA Roselyne Pediater's annual accounts

20252024202320222021
Net result23,694 €
Equity5,473 €
Cash89,619 €
EBITDA86,344 €
Total assets304,521 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 24 Dec 2025
  • Year ended 30 Jun 2024filed on 21 Dec 2024
  • Year ended 30 Jun 2023filed on 21 Dec 2023
  • Year ended 30 Jun 2022filed on 21 Dec 2022
  • Year ended 30 Jun 2021filed on 30 Dec 2021

Dr. UWERA Roselyne Pediater's financial analysis

Management and control of Dr. UWERA Roselyne Pediater

1 active director(s) in the register.

Dr. UWERA Roselyne Pediater's shareholders and holdings →

Dr. UWERA Roselyne Pediater's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0743.380.680
VAT number
No VAT activity declared to the CBE
Peppol
Registered · 0208:0743380680 · as of 10 Nov 2026
Legal form
SRL
Incorporated
06 Feb 2020
Registered office
3350 Linter
Latest accounts
2025 · filed on 24 Dec 2025

Dr. UWERA Roselyne Pediater (SRL) has been based in Linter since 2020, active in: —. For 2025, it reports a net profit of 23,694 € and equity of 5,473 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. UWERA Roselyne Pediater

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. UWERA Roselyne Pediater

What is the revenue of Dr. UWERA Roselyne Pediater?

Dr. UWERA Roselyne Pediater files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. UWERA Roselyne Pediater?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. UWERA Roselyne Pediater. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0743380680. Its company number (CBE) is 0743.380.680.

Where is the registered office of Dr. UWERA Roselyne Pediater?

According to the CBE register, the registered office of Dr. UWERA Roselyne Pediater is in 3350 Linter.

What is the equity of Dr. UWERA Roselyne Pediater?

At the close of the 2025 financial year, the equity of Dr. UWERA Roselyne Pediater amounts to 5,473 €, a solvency of 1.8% of total assets.

Who manages Dr. UWERA Roselyne Pediater?

The register lists 1 active mandates at Dr. UWERA Roselyne Pediater. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. UWERA Roselyne Pediater

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 11 Aug 2026

No credit card, no commitment.

What each plan unlocks →